Image: StatnewsDissecting Chinese trial strategy in wake of deaths
• Merck and Moderna reported that their experimental cancer "vaccine" successfully slowed the progression of melanoma. • The report also examines and dissects the trial strategies employed by Chinese researchers following recent patient deaths. • These developments highlight critical advancements in personalized immunotherapy and the ongoing scrutiny of clinical trial safety protocols.
statnews.com

